Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up - Molinaro, E; Giani, C; Agate, L (J Clin Endocrinol Metab, 2013)
et al.